Cryptogenic organizing pneumonia laboratory findings: Difference between revisions

Jump to navigation Jump to search
Manpreet Kaur (talk | contribs)
Manpreet Kaur (talk | contribs)
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 5: Line 5:


==Overview==
==Overview==
 
There are no specific laboratory findings associated with [[cryptogenic organizing pneumonia]]. If there are symptoms of [[fever]], [[cough]] and [[dyspnea]], then tests like [[CBC]], [[creatinine]], [[urinalysis]], [[ESR]], [[CRP]]. Further tests are done to rule out the etiology of the [[cryptogenic organizing pneumonia]].
==Laboratory Findings==
==Laboratory Findings==
*There are no specific laboratory findings associated with [[cryptogenic organizing pneumonia]].
*There are no specific laboratory findings associated with [[cryptogenic organizing pneumonia]].
*If there is the history of [[cryptogenic organizing pneumonia]] then following laboratory test is done:
*If there is the history of [[cryptogenic organizing pneumonia]] and patients present with a [[cough]], [[fever]], and [[dyspnea]] then following laboratory test has to be done:<ref name="pmid6647749">{{cite journal |vauthors=Davison AG, Heard BE, McAllister WA, Turner-Warwick ME |title=Cryptogenic organizing pneumonitis |journal=Q. J. Med. |volume=52 |issue=207 |pages=382–94 |date=1983 |pmid=6647749 |doi= |url=}}</ref>
 
**[[Complete blood count]] with differentials- [[leukocytosis]] is found in most of the patients.<ref name="pmid8313672">{{cite journal |vauthors=Cordier JF |title=Cryptogenic organizing pneumonitis. Bronchiolitis obliterans organizing pneumonia |journal=Clin. Chest Med. |volume=14 |issue=4 |pages=677–92 |date=December 1993 |pmid=8313672 |doi= |url=}}</ref>
In patients with typical clinical and radiographic features, a transbronchial biopsy that shows the pathologic pattern of organizing pneumonia and lacks features of an alternative diagnosis is adequate to make a tentative diagnosis and start therapy. On surgical lung biopsy, the histopathologic pattern is organizing pneumonia with preserved lung architecture; this pattern is not exclusive to BOOP and must be interpreted in the clinical context. Most patients recover with corticosteroid therapy. A standardized approach to dosing starting at 0.75 mg/kg and weaning over 24 weeks has been shown to reduce total corticosteroid exposure without affecting outcome.
**[[Blood urea nitrogen]]
**[[Creatinine]]
**[[Urinalysis]]
**[[ESR]]
**[[C-reactive protein]]
*To find the etiology of [[cryptogenic organizing pneumonia]] following tests are done:
**Test for [[antibodies]] to rule out [[connective tissue]] disorder.
***[[Antinuclear antibody]]
***[[Rheumatoid factor]]
***[[Anti-topoisomerase antibodies|Anti-topoisomerase]] [anti-Scl70] antibodies
***[[Anti-centromere antibodies]]
***Anti-double-stranded DNA antibodies
***Anti-J01 antibodies
**To rule out [[pneumonia]], following tests are done:<ref name="pmid26407727">{{cite journal |vauthors=Disayabutr S, Calfee CS, Collard HR, Wolters PJ |title=Interstitial lung diseases in the hospitalized patient |journal=BMC Med |volume=13 |issue= |pages=245 |date=September 2015 |pmid=26407727 |pmc=4584017 |doi=10.1186/s12916-015-0487-0 |url=}}</ref>
***[[Blood culture|Blood cultures]]
***Sputum [[gram stain]]
***Sputum [[Enzyme linked immunosorbent assay (ELISA)|enzyme immunoassay]] (EIA)
***[[Immunofluorescence]]
***[[Polymerase chain reaction]] (PCR) for respiratory viruses
***Urinary studies for [[pneumococcal]] and [[Legionella]] antigen
***[[HIV testing]]


==References==
==References==

Latest revision as of 02:51, 7 March 2018

Cryptogenic Organizing Pneumonia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cryptogenic organizing pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Electrocardiogram

Ultrasonography/Echocardiography

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cryptogenic organizing pneumonia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cryptogenic organizing pneumonia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cryptogenic organizing pneumonia laboratory findings

CDC on Cryptogenic organizing pneumonia laboratory findings

Cryptogenic organizing pneumonia laboratory findings in the news

Blogs on Cryptogenic organizing pneumonia laboratory findings

Directions to Hospitals Treating Cryptogenic organizing pneumonitis

Risk calculators and risk factors for Cryptogenic organizing pneumonia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

There are no specific laboratory findings associated with cryptogenic organizing pneumonia. If there are symptoms of fever, cough and dyspnea, then tests like CBC, creatinine, urinalysis, ESR, CRP. Further tests are done to rule out the etiology of the cryptogenic organizing pneumonia.

Laboratory Findings

References

  1. Davison AG, Heard BE, McAllister WA, Turner-Warwick ME (1983). "Cryptogenic organizing pneumonitis". Q. J. Med. 52 (207): 382–94. PMID 6647749.
  2. Cordier JF (December 1993). "Cryptogenic organizing pneumonitis. Bronchiolitis obliterans organizing pneumonia". Clin. Chest Med. 14 (4): 677–92. PMID 8313672.
  3. Disayabutr S, Calfee CS, Collard HR, Wolters PJ (September 2015). "Interstitial lung diseases in the hospitalized patient". BMC Med. 13: 245. doi:10.1186/s12916-015-0487-0. PMC 4584017. PMID 26407727.